The development of ischemic contracture and subsequent contraction band necrosis has been known to be more rapid in the hypertrophied than non-hypertrophied heart, and to occur first in the subendocardial layers of the left ventricle. The temporal correlation of metabolic abnormalities with structural alterations is much less clear, and the influence of non-hemodynamic factors on the development of subendocardial necrosis has received very little study. The hypothesis being tested is that there are metabolic differences in cardiac myocytes of subendocardial versus subepicardial tissue which occur independant of pressure and flow related changes and that these differences are accentuated in cardiac hypertrophy. These metabolic changes render the subendocardium more susceptible to ischemic cell death. We plan to study the development of cellular metabolic and structural changes in the isolated rat heart arrested with KC1 and under constant left ventricular pressure to avoid the influence of hemodynamic variables in the intact heart. We will utilize the isolated myocyte preparations to study myocyte response to anoxic conditions a) without the influence of other cellular components, and b) after one to two days and 1 and 2 weeks in culture to provide further temporal removal from in vivo hemodynamic effects. We will use morphological methods to identify time and location of ischemic myocardial alterations in relation to regional metabolic alterations in these normal and hypertrophied hearts. HPLC analysis will be used to quantitatively evaluate regional differences in adenine nucleotides and their metabolites. Finally, myosin isozymes will be analyzed to evaluate changes which may have occurred in contractile protein properties in hypertrophied myocardium. The results of these studies should provide information correlating metabolic and morphologic changes in hypertrophied myocardium and provide a better understanding for the increased susceptibility of the hypertrophied heart to ischemic heart disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL036892-02
Application #
3352233
Study Section
Cardiovascular Study Section (CVA)
Project Start
1986-09-30
Project End
1989-09-29
Budget Start
1987-09-30
Budget End
1988-09-29
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
School of Medicine & Dentistry
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Machida, N; Brissie, N; Sreenan, C et al. (1997) Inhibition of cardiac myocyte division in c-myc transgenic mice. J Mol Cell Cardiol 29:1895-902
Gu, X; Bishop, S P (1994) Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res 75:926-31
Allard, M F; Emanuel, P G; Russell, J A et al. (1994) Preischemic glycogen reduction or glycolytic inhibition improves postischemic recovery of hypertrophied rat hearts. Am J Physiol 267:H66-74
McDaniel, H G; Jenkins, R; McDaniel, R (1993) Conditions for glutamate dehydrogenase activity in heart mitochondria. Biochem Med Metab Biol 50:75-84
Jackson, T; Allard, M F; Sreenan, C M et al. (1991) Transgenic animals as a tool for studying the effect of the c-myc proto-oncogene on cardiac development. Mol Cell Biochem 104:15-9
Allard, M F; Doss, L K; Bishop, S P (1990) Verapamil does not prevent isoproterenol-induced cardiac hypertrophy. Am J Cardiovasc Pathol 3:167-74
Bugaisky, L B; Anderson, P G; Hall, R S et al. (1990) Differences in myosin isoform expression in the subepicardial and subendocardial myocardium during cardiac hypertrophy in the rat. Circ Res 66:1127-32
Anderson, P G; Allard, M F; Thomas, G D et al. (1990) Increased ischemic injury but decreased hypoxic injury in hypertrophied rat hearts. Circ Res 67:948-59
Tucker, D C; Bishop, S P (1990) Use of embryonic heart grafted in oculo to assess neurohumoral controls of cardiac development. Toxicol Pathol 18:531-40
Bishop, S P (1990) The myocardial cell: normal growth, cardiac hypertrophy and response to injury. Toxicol Pathol 18:438-53

Showing the most recent 10 out of 15 publications